Why Moderna Shares Are Rising Today

Moderna Inc MRNA is trading higher Monday amid increasing concerns surrounding the omicron COVID-19 variant. 

Omicron has more than 30 mutations on the spike protein that binds to human cells, according to a World Health Organization report. The mutations suggest higher transmission rates and potentially reduced antibody protection.

The U.S. banned entry to non-citizens that have traveled from South Africa during the past 14 days. The U.K. and other countries have implemented similar travel restrictions. 

Moderna CEO Stéphane Bancel suggested Monday morning that a higher dose of Moderna's booster vaccine could be effective against the omicron variant.

Related Link: Moderna CEO Weighs In On Omicron Variant: We Believe It's 'Already Present In Most Countries'

Moderna is a commercial-stage biotech company. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the U.S. in December 2020.

MRNA Price Action: Moderna has traded as high as $497.49 and as low as $98.65 over a 52-week period.

The stock was up 7.76% at $354.88 at time of publication.

Photo: mufidpwt from Pixabay.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: NewsHealth CareGlobalGeneralStephane Bancelwhy it's moving
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!